METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE

    公开(公告)号:US20250101117A1

    公开(公告)日:2025-03-27

    申请号:US18820893

    申请日:2024-08-30

    Abstract: This disclosure relates to methods, uses, and compositions (e.g., articles of manufacture and kits) comprising an anti-OSMRβ antibody, such as vixarelimab, for the treatment of inflammatory gastrointestinal diseases associated with the oncostatin M (OSM) pathway (e.g., inflammatory bowel disease (IBD) (e.g., ulcerative colitis (UC (e.g., moderate to severe UC)) and Crohn's disease (CD)).

Patent Agency Ranking